Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Mallinckrodt
Express Scripts
Medtronic
UBS
Accenture
QuintilesIMS
Harvard Business School
Moodys

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: RE40045

« Back to Dashboard

Summary for Patent: RE40045
Title:Medicaments
Abstract:Pharmaceutical compositions comprising effective amounts of salmeterol (and a physiologically acceptable salt thereof) and fluctuations propionate as a combined preparation for simultaneous, sequential or separate administration by inhalation in the treatment of respiratory disorders.
Inventor(s): Palmer; James B. D. (Princeton, NJ)
Assignee: Glaxo Group Limited (Greenford, GB)
Application Number:10/933,483
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;

Drugs Protected by US Patent RE40045

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: RE40045

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8920392Sep 08, 1989
United Kingdom8923644Oct 20, 1989

International Patents Family Members for US Patent RE40045

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom 9019659 ➤ Subscribe
France 2651677 ➤ Subscribe
Switzerland 680983 ➤ Subscribe
Cyprus 1817 ➤ Subscribe
Germany 19975040 ➤ Subscribe
Germany 69005951 ➤ Subscribe
Denmark 0416951 ➤ Subscribe
European Patent Office 0416951 ➤ Subscribe C990012 Netherlands ➤ Subscribe
European Patent Office 0416951 ➤ Subscribe 12/1999 Austria ➤ Subscribe
Spain 2062392 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Boehringer Ingelheim
Mallinckrodt
Healthtrust
AstraZeneca
Fuji
US Army
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot